Ads
related to: acute myeloid leukemia treatment- Mechanism Of Action
Learn How To Treat Patients
With Ph+ CML-CP Today.
- Treatment Option
Visit The Physician Website To
Learn More About This Treatment.
- Efficacy Information
Physicians, See How This Treatment
May Help Your Patients Today.
- View Patient Profiles
Patients Experience Treatment
Intolerance & Suboptimal Responses
- Safety Profile
Physicians, See Important Safety
Information About This Treatment.
- $0 Co-Pay Information
Patients With Private Insurance
Could Save On Their Prescription.
- Mechanism Of Action
Search results
Moleculin Announces Formation of Scientific Advisory Board to Support Development of Annamycin
KTLA-TV Los Angeles· 18 hours agoMartin Tallman. Dr. Tallman is an internationally renowned clinical investigator whose discoveries have fueled the progress of leukemia-targeting therapies, most recently ...
Hemogenyx Pharmaceuticals outlines significant progress with HEMO-CAR-T in 2023
Proactive Investors· 6 days agoAfter re-manufacturing the lentivirus, Hemogenyx successfully addressed the FDA's concerns and...
Senti Biosciences reports breakthrough in AML treatment By Investing.com
Investing.com· 2 days agoThis data, which was recently published in the journal Cell Reports, highlights the ability of...
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer...
Benzinga· 3 days agoMorphoSys AG MOR is reportedly facing a burgeoning safety concern surrounding pelabresib, an...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 7 days agoThat could be why the first generation of radiopharmaceuticals were flops, Seth, the Actinium CEO,...
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
Morningstar· 2 days agoCuris, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company ...
Affimed (NASDAQ:AFMD) Short Interest Update
ETF DAILY NEWS· 3 days agoAffimed (NASDAQ:AFMD – Get Free Report) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 219,400 shares, an increase ...
Secondary cancer: Why breast cancer survivors have a higher risk
Medical News Today· 7 days agoThe age of cancer diagnosis appears to affect second cancer risk, especially for women, as does economic status. In it, researchers from the University of Cambridge in England report that women ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoSAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the ...
Kura Oncology, Inc. (NASDAQ:KURA) Stock Holdings Lessened by Mirae Asset Global Investments Co. Ltd.
ETF DAILY NEWS· 6 days agoMirae Asset Global Investments Co. Ltd. lessened its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 5.7% in the fourth quarter, according to the company in its most ...
Ads
related to: acute myeloid leukemia treatment